Singh et al., in a study from 2013, showed through an administrative database study of U.S. adults with type 2 diabetes mellitus that treatment with the GLP-1-based therapies sitagliptin and exenatide was associated with the increased odds of hospitalization for acute pancreatitis [5]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.